Late-breaking news from #ASTRO26: Alliance for Clinical Trials in Oncology Phase III trial (A071801) finds 3-5 sessions of radiosurgery after surgery for large brain metastases outperforms single-session treatment in reducing local recurrence and boosting survival. https://bit.ly/ASTRO26

With colorectal cancer, if a person has an inherited gene change, other family members are at risk. Alliance A212101 will see if family members are more likely to get genetic testing to catch disease early if they hear from a healthcare provider. More at https://bit.ly/CRCGene-Testing

FDA approves new treatment option, atezolizumab in combination with chemotherapy, for patients with stage III dMMR colon cancer based on results from the phase III ATOMIC trial led by Alliance. Learn more at https://bit.ly/FDA-ATOMIC #NCI #NCTN #CancerResearch #CRCsm

Now enrolling! Bhavana Konda, MD, MPH, of Ohio State leads ALLIANCE A092204 exploring if using two targeted drugs can help slow tumor growth in #AYA with advanced adrenocortical carcinoma, a rare cancer of the adrenal glands. https://bit.ly/A092204-Konda #clinicaltrials

NOW ON DEMAND 🎥 Catch up on the latest cancer advanced presented by Alliance researchers at the 2026 ASCO Annual Meeting. Watch our webinar with the investigators and patient advocates discussing breakthroughs in breast, lung, and prostate cancers: https://bit.ly/BestofASCO26

📰 Media highlights featuring Alliance research: 🧠 ASTRO '26: Multi-fraction SRS reduces brain met recurrence 🩸 ALL: Pediatric regimen effective in adults 40+ 🩺 Breast Cancer: FDA approval backed by AFT-38/PATINA
Full roundup: https://bit.ly/Sept-Media #ASTRO26 #clinicaltrials

Brad McGregor of Dana-Farber Cancer Institute leads Alliance for Clinical Trials in Oncology
A032201 (STRIKE) to see if adding the drug tivozanib to the standard treatment of immunotherapy after surgery helps patients with high-risk renal cell cancer. More: https://bit.ly/Alliance-A032201

Now enrolling! Dr. Deepak Kilari from @MedicalCollege is now enrolling @ALLIANCE-org A032302, the ASPIRE trial to see if adding chemo to hormone therapy improves survival in men with metastatic #prostatecancer. To learn more, visit http://bit.ly/AllianceA032302. #clinicaltrials #PCSM

ERAsur has gone global! Led by Dr. Eric Miller of Ohio State leads Alliance A022101 aimed at improving colorectal cancer survival is now active to patients in Canada and Mexico with sites in Colombia and Chile expected to begin later this month. https://bit.ly/ERAsur

Clinical trials help advance cancer research and care—but they depend on people willing to participate. Our new film shares one participant’s story and the vital role volunteers like her play in improving cancer treatment. Watch the #RewritingCancer film: https://bit.ly/Alliance-Video

Now enrolling! Dr. Gabriel Brooks Dartmouth Cancer leads the PAGODA trial (A232402CD) aimed at reducing unplanned treatment delays in people with gastrointestinal cancers. Learn more at https://bit.ly/PAGODA26. #ColorectalCancer #OncTwitter #gism #MedTwitter #ClinicalTrials

Alliance Foundation Trials and Natera have launched AFT-70 NAVIGATE, a global Phase III trial in ER+/HER2- early-stage breast cancer, evaluating giredestrant, Genentech’s investigational oral SERD, with Signatera™ MRD-guided CDK4/6 inhibitor therapy. Learn more: bit.ly/4rKzlbQ #AFT #BreastCancer

Now enrolling: Alliance A071401 led by Dr. Priscilla Brastianos of Mass General leads a new trial enrolling patients with progressive meningioma. This study evaluates biomarker-driven targeted agents based on specific genetic mutations. Full protocol at 👇 🔗 https://bit.ly/A071401-trial

New lung cancer trial open 🧪🫁
Alliance A082402 is studying if targeted post op radiation (I² PORT) can reduce recurrence in high risk #NSCLC patients after surgery while limiting side effects. Learn more https://bit.ly/I-PORT-Trial. #LungCancer #ClinicalTrials #RadiationTherapy

Results from the Alliance RadiCaL (A031801) trial led by Dr. Rana McKay in JCO by American Society of Clinical Oncology found that adding radium-223 does not improve time people with kidney cancer went without bone complications. News - https://bit.ly/Radical26. Article - https://bit.ly/Radical-JCO

Discover the latest advances in breast, lung & prostate cancer care! Join the Alliance for a free public webinar on Oct 1 featuring leading researchers & patient advocates sharing key findings from #ASCO26. Register now: bit.ly/Alliance-Webinar-Oct26 #clinicaltrials

More than 192K Americans will face a blood cancer diagnosis this year—one every 3 minutes. This #BloodCancerAwarenessMonth, the Alliance is highlighting 11 active trials driving research in precision therapies, immunotherapy, and survivorship. More at https://bit.ly/BloodCa

Now enrolling! Led by Maryam Lustberg, a new trial tackles a common but overlooked side effect of breast cancer treatment. The #REVITALIZE study (Alliance A221801) is testing laser therapy to relieve chronic vaginal dryness and improve quality of life for survivors. 💗🧪 https://bit.ly/REVITALIZE2026

Late-breaking news from #ASTRO26: Alliance for Clinical Trials in Oncology Phase III trial (A071801) finds 3-5 sessions of radiosurgery after surgery for large brain metastases outperforms single-session treatment in reducing local recurrence and boosting survival. https://bit.ly/ASTRO26

Enrolling! Drs. Thomas Hope of UCSF Helen Diller Family Comprehensive Cancer Center and Suki Padda of @foxchasecancer.bsky.social lead A021901/B-LuRE trial comparing a radioactive drug to chemotherapy treatment in patients with bronchial #neuroendocrine tumors. More: https://bit.ly/Alliance-A021901